The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO 2019 | Future treatment options for squamous cell lung cancer

Name: Future treatment options for squamous cell lung cancer
Uploaded: 2019-06-03T00:00:00Z
Duration: 53 s
Description: Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.

Paul Paik • 3 Jun 2019

ASCO 2019

Lung Cancer

Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.